Investing
Tonix’s long COVID drug fails to meet mid-stage trial goal
© Reuters. FILE PHOTO: The word “COVID-19” is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – Tonix Pharmaceuticals Holding Corp said on Tuesday its experimental drug failed to meet the primary goal in a mid-stage study for management of widespread muscle pain and tenderness associated with long COVID-19.
Shares of the company were down 12% in premarket trading.
The 63-patient study was designed to monitor the intensity of pain in patients who had long COVID and administered either the drug, TNX-102 SL, or placebo, but the trial failed to show improvement at week 14 of treatment, the company said.
However, the study showed that the drug helped reduce fatigue and improve sleep quality and cognitive function in the patients, the company said.
Tonix intends to meet officials from the U.S. Food and Drug Administration in early 2024 to seek permission to conduct a late-stage trial that focuses on reducing fatigue in patients with long COVID, an illness with no approved drugs.
Read the full article here
A 5-Minute Guide to Building a Legacy Team
Entrepreneurs Can Learn ChatGPT with This $30 Bundle
Black Friday Has Arrived: This MacBook Air Has Had Its Price Slashed by More Than 70%
Why 2025 Will Be Your Most Amazing Year Yet as an Entrepreneur
EU regulators scrap merger power aimed at killer acquisitions after court veto By Reuters
This All-Access Pass to Learning Is Now $20 for Black Friday
How to Create a Routine That Balances Rest and Business Success
A Macy’s Employee Made Accounting Errors Worth $132 Million
Factbox-How Trump can overhaul US financial regulators when he takes office By Reuters
5 Ways AI Can Accelerate Your Entrepreneurial Journey
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Investing6 days agoThis All-Access Pass to Learning Is Now $20 for Black Friday
-
Passive Income6 days agoHow to Create a Routine That Balances Rest and Business Success
-
Side Hustles4 days agoA Macy’s Employee Made Accounting Errors Worth $132 Million
-
Investing3 days agoFactbox-How Trump can overhaul US financial regulators when he takes office By Reuters
-
Passive Income3 days ago5 Ways AI Can Accelerate Your Entrepreneurial Journey
-
Side Hustles6 days agoGift the Power of Language Learning with This Limited-Time Price on Babbel
-
Side Hustles2 days agoClosing Your Business? Do It Before the New Year to Save Money
-
Side Hustles6 days agoI’ve Spent 20 Years Studying Focus. Here’s How I Use AI to Multiply My Time and Save 21 Weeks of Work a Year